Product category:
Liquid handling
News Release from: Molecular Devices | Subject: Fliprtetra
Edited by the Laboratorytalk Editorial
Team on 04 June 2004
Screening with simultaneous 1536 liquid
transfer
Microplate detection system simultaneously transfers liquid to 1536-well microplates, significantly reducing screening time and reagent consumption
Molecular Devices has introduced Fliprtetra, which it says is the first system that enables researchers to significantly increase throughput of cell-based assays by measuring 1536 kinetic measurements simultaneously Fliprtetra is the only microplate detection system that simultaneously transfers liquid to 1536-well microplates, significantly reducing screening time and reagent consumption, says the company
This article was originally published on Laboratorytalk on 13 Jun 2008 at 8.00am (UK)
Related stories
MDS introduces new systems for genomics research
New Axon GenePix microarray scanners and Arcturus laser capture microdissection instrument improve research speed and precision
Laser capture microdissection taken to next level
The ArcturusXT system uses the latest advances in microscope technology by employing the new Nikon Eclipse Ti-E inverted research microscope as its base
This entirely new, modular system also offers traditional 96- and 384-well fluidics, easily convertible by the user within minutes, providing a seamless transition between higher-volume assays to those that require sub-microlitre volume additions.
Fliprtetra is also the first Flipr system to offer an expanded set of excitation wavelengths, significantly broadening its use beyond traditional calcium mobilization and membrane potential assays.
"Flipr is the most widely-used screening system for GPCR analysis," stated Michael Biros, marketing director for drug discovery instruments at Molecular Devices.
"With Fliprtetra, researchers can now increase the throughput and reduce the cost of their calcium mobilisation and membrane potential assays even more -screening over 3000 kinetic assays every six minutes using a few thousand cells per assay".
Commenting on the launch of the Fliprtetra, Stephen Oldfield, Molecular Devices's vice president of worldwide marketing, stated: "Development of Fliprtetra was guided by senior-level drug discovery managers striving to reduce facilities and screening costs, as well as thousands of Flipr users looking to improve ease-of-use and robustness.
Oldfield further noted: "The Fliprtetra brings the multi-wavelength capability that our FlexStation users have enjoyed to a high-throughput platform, paving the way for multi-wavelength applications. Request a free brochure from Molecular Devices ...
"This new instrument platform also extends the user base for our growing family of reagent kits, including Calcium 3 and membrane potential kits.".
• Molecular Devices: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
